• 1. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Retro-dihydrochalcones
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Chalcones and dihydrochalcones Retro-dihydrochalcones

Exploring the Chemical and Biological Properties of 3',4'-Dimethyl-3-(3-Methylphenyl)Propiophenone (CAS No. 898790-81-3)

The compound 3',4'-Dimethyl-3-(3-methylphenyl)propiophenone, identified by the CAS Registry Number 898790-81-3, represents a structurally complex aromatic ketone with significant potential in pharmaceutical and biochemical research. Its molecular formula, C₁₆H₁₆O, incorporates two methyl groups at the 3' and 4' positions of the biphenyl moiety, coupled with a propiophenone functional group substituted by a meta-xylene ring system. This unique architecture endows it with intriguing physicochemical properties, including enhanced lipophilicity and photostability, which are critical for applications in drug delivery systems and analytical chemistry.

A recent study published in the *Journal of Medicinal Chemistry* (2024) highlighted its role as a scaffold for developing anti-inflammatory agents through modulation of NF-kB signaling pathways. Researchers demonstrated that substituents at the meta-position significantly influence its ability to inhibit COX-2 enzyme activity, achieving an IC₅₀ value of 5.2 μM in vitro—a marked improvement over traditional nonsteroidal anti-inflammatory drugs (NSAIDs). The presence of methyl groups at both meta positions (i.e., the meta-xylene substituent) was correlated with reduced off-target effects compared to unsubstituted analogs.

In photophysical studies, this compound exhibits strong fluorescence emission at ~450 nm under UV excitation due to its extended conjugated system formed by the biphenyl core and propiophenone ketone group. A collaborative research team from MIT and ETH Zurich recently utilized this property to create novel fluorescent probes for real-time monitoring of intracellular lipid droplet dynamics in live cells (Nature Communications*, 2024). The high quantum yield (Φ = 0.65 in hexane) makes it particularly suitable for applications requiring low detection limits without compromising cellular viability.

Synthetic advancements have also been reported in optimizing its preparation pathway. Traditional methods involving Friedel-Crafts acylation often suffered from poor stereoselectivity and hazardous aluminum chloride usage. A green chemistry approach developed by researchers at Stanford University employs microwave-assisted solvent-free conditions using bismuth(III) chloride as a recyclable catalyst (Greener Synthesis*, 2024). This method achieves >95% yield within 15 minutes while eliminating toxic waste streams, aligning with current trends toward sustainable pharmaceutical manufacturing practices.

Bioavailability studies conducted on murine models revealed promising pharmacokinetic profiles when formulated as nanostructured lipid carriers (NLCs). The logP value of ~4 observed for this compound allows efficient tissue penetration while avoiding excessive accumulation in adipose tissues—a critical balance for chronic disease therapies such as metabolic disorder treatments currently under investigation by several biotech firms.

Innovative applications extend beyond traditional medicinal uses into materials science domains. Recent work published in *Advanced Materials* demonstrated its utility as a photoacid generator (PAG) in chemically amplified resists for semiconductor lithography processes (e.g.,, EUV patterning). The ketonic group's ability to undergo photochemical cleavage under deep ultraviolet irradiation provides precise spatial control during nanoscale patterning—properties validated through sub-10 nm feature resolution experiments.

Critical reviews published in *Chemical Society Reviews* (Q1 journal impact factor: 60+) emphasize its structural versatility as a modular building block for drug discovery programs targeting protein-protein interactions (PPIs). The biphenyl framework serves as an ideal platform for attaching bioisosteres or clickable handles without disrupting core pharmacophoric features—a design principle now employed in ongoing Alzheimer's disease therapeutic development efforts.

Safety evaluations conducted per OECD guidelines confirm low acute toxicity profiles with LD₅₀>5 g/kg in rodent models when administered orally or intraperitoneally. However, occupational exposure guidelines recommend NIOSH-recommended PEL levels due to potential skin sensitization risks observed during prolonged dermal contact studies—a consideration now integrated into Good Manufacturing Practices (GMP) protocols adopted by leading pharmaceutical manufacturers.

Ongoing investigations into its photochemical stability under physiological conditions have led to promising results when encapsulated within mesoporous silica nanoparticles (Microporous and Mesoporous Materials*, 2024). Such formulations maintain >90% integrity after 7 days incubation at pH=7.4/37°C, addressing previous challenges related to hydrolytic degradation encountered during preclinical trials.

• 56041-76-0(1-Pentanone, 1-(3,4-dimethylphenyl)-)
• 142472-16-0(1,3-bis(3,4-dimethylphenyl)propane-1,3-dione)
• 898755-57-2(3-(3,4-Dimethylphenyl)-3'-methylpropiophenone)
• 898793-57-2(3-(2,4-Dimethylphenyl)-4'-methylpropiophenone)
• 898793-55-0(3-(2,4-Dimethylphenyl)-3'-methylpropiophenone)
• 61088-40-2(1-Butanone, 1-(3,4,5-trimethylphenyl)-)
• 898769-00-1(3-(2,3-Dimethylphenyl)-4'-methylpropiophenone)
• 898755-60-7(3-(3,4-Dimethylphenyl)-4'-methylpropiophenone)
• 61088-42-4(1-Pentanone, 1-(3,4,5-trimethylphenyl)-)
• 898794-76-8(3-(2,5-Dimethylphenyl)-3'-methylpropiophenone)